Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Innovent to Raise $422 Million in Hong Kong IPO at $2 Billion Valuation
Fosun Pharma Officially Announces Plan for Henlius IPO in Hong Kong
Zhejiang Anglikang Pharma Approved for $87 Million IPO in Shenzhen
WuXi AppTec Files for $1 Billion-Plus IPO in Hong Kong
Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events



November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"